WELLS FARGO & COMPANY/MN - NEUROONE MED TECHNOLOGIES CO ownership

NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 19 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of NEUROONE MED TECHNOLOGIES CO
ValueSharesWeighting
Q1 2024$232
-16.2%
193
+10.3%
0.00%
Q4 2023$277
+87.2%
175
+5.4%
0.00%
Q3 2023$148
+3.5%
166
+39.5%
0.00%
Q2 2023$143
-16.4%
119
+12.3%
0.00%
Q1 2023$171
+36.8%
106
+1.9%
0.00%
Q4 2022$125104
+3.0%
0.00%
Q3 2022$0101
+16.1%
0.00%
Q2 2022$087
+8.8%
0.00%
Q1 2022$080
+3.9%
0.00%
Q4 2021$077
+42.6%
0.00%
Q3 2021$0540.00%
Other shareholders
NEUROONE MED TECHNOLOGIES CO shareholders Q2 2024
NameSharesValueWeighting ↓
Mayo Clinic 181,754$218,1050.12%
DRIVE WEALTH MANAGEMENT, LLC 64,203$77,0440.04%
Virtu Financial LLC 14,939$180.00%
MAI Capital Management 50,000$60,0000.00%
OSAIC HOLDINGS, INC. 350$00.00%
GEODE CAPITAL MANAGEMENT, LLC 114,249$1370.00%
Citadel Advisors 7,300$8,7600.00%
Citadel Advisors 100$1200.00%
Citadel Advisors 36,098$43,3180.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 85,926$103,1110.00%
View complete list of NEUROONE MED TECHNOLOGIES CO shareholders